These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 24499452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S, Babaoğlu K, Başar EZ, Deveci M, Çorapçıoğlu F.
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [Abstract] [Full Text] [Related]

  • 5. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM, Groot-Loonen J, Bellersen L, Pourier MS, Feuth T, Bökkerink JP, Hoogerbrugge PM, Kapusta L.
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [Abstract] [Full Text] [Related]

  • 6. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N.
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines.
    Pourier MS, Kapusta L, van Gennip A, Bökkerink JP, Loonen J, Bellersen L, Mavinkurve-Groothuis AM.
    Clin Chim Acta; 2015 Feb 20; 441():29-32. PubMed ID: 25512165
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
    Oberholzer K, Kunz RP, Dittrich M, Thelen M.
    Rofo; 2004 Sep 20; 176(9):1245-50. PubMed ID: 15346258
    [Abstract] [Full Text] [Related]

  • 12. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors.
    De Wolf D, Suys B, Maurus R, Benoit Y, Verhaaren H, Matthijs D, Otten J.
    Pediatr Res; 1996 Mar 20; 39(3):504-12. PubMed ID: 8929873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
    Toro-Salazar OH, Gillan E, O'Loughlin MT, Burke GS, Ferranti J, Stainsby J, Liang B, Mazur W, Raman SV, Hor KN.
    Circ Cardiovasc Imaging; 2013 Nov 20; 6(6):873-80. PubMed ID: 24097420
    [Abstract] [Full Text] [Related]

  • 15. Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors.
    De Caro E, Smeraldi A, Trocchio G, Calevo M, Hanau G, Pongiglione G.
    Pediatr Blood Cancer; 2011 Jan 20; 56(1):122-6. PubMed ID: 21058389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM, Rai SN, Nunez C, Merchant TE, Marina NM, Zalamea N, Cox C, Phipps S, Pompeu R, Rosenthal D.
    J Clin Oncol; 2007 Aug 20; 25(24):3635-43. PubMed ID: 17704413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.